Executive Summary
Federal contracts totaling $6.17B in obligations highlight DOE's dominant $2.37B commitment to Savannah River Mission Completion LLC for long-term nuclear remediation, representing 38% of volume with $8.4B option ceiling. Bullish signals across defense R&D, health IT, biotech, and security underscore stable revenue through 2032, with $10B+ in unobligated options for upside. No bearish indicators, but long durations and firm-fixed structures flag execution risks amid high outlays in some ($2.7B total).
Tracking the trend? Catch up on the prior General Federal Contracts digest from March 06, 2026.
Investment Signals(3)
- DOE Nuclear Remediation Scale-Up(HIGH)▲
Two awards to Savannah River Mission Completion LLC total $2.37B obligated ($8.4B ceiling) for 8-year liquid waste/tank closure at Savannah River site, with $1.97B outlayed signaling execution momentum.
- Defense & IT Services Momentum(HIGH)▲
SAIC's $1.44B GSA defense R&D order (to $2.9B ceiling) and Oracle's $1.28B VA EHRM hosting (to 2026) provide multi-year visibility in Huntsville/Kansas City hubs.
- Biotech & Infrastructure Longevity(MEDIUM)▲
Amgen's 10-year $774M HHS BARDA award ($712M outlayed) and GardaWorld's $313M DHS detention facility order (to $704M by 2029) lock in decade-long federal revenue.
Risk Flags(2)
- Execution[HIGH RISK]▼
Long 5-10 year periods expose to cost overruns (firm-fixed in Amgen/Oracle/GardaWorld) and zero/low outlays (Oracle $0, SAIC negative, GardaWorld $0 pre-2026 start).
- Regulatory[MEDIUM RISK]▼
DOE mission shifts or HHS R&D uncertainties over 8-10 years; high subawards (SAIC $981M/598 subs) add subcontractor dependency.
Opportunities(2)
- ◆
$10B+ unobligated options (e.g., Savannah River $5.3B+$762M, SAIC $1.46B) tied to performance through 2031-2032.
- ◆
Repeatable full/open competition wins position large contractors for follow-ons in remediation (DOE), biotech (HHS), and IT (VA/GSA).
Sector Themes(2)
- ◆
38% of value in Savannah River liquid waste/tank closure signals sustained nuclear cleanup spend through 2031.
- ◆
VA/HHS/GSA awards emphasize EHRM/biotech/defense R&D with $3.5B obligations and minimal competition.
Watch List(3)
- 👁
{"entity"=>"Savannah River Mission Completion LLC", "reason"=>"Concentration risk/opportunity at 38% of period value with $8.4B ceiling.", "trigger"=>"Option funding in DOE FY2027+ or outlay >$2.5B"}
- 👁
{"entity"=>"SAIC", "reason"=>"Largest non-DOE award with $1.5B options and subaward leverage.", "trigger"=>"Follow-on GSA defense R&D post-2025"}
- 👁
{"entity"=>"DOE Savannah River Site", "reason"=>"Hub for $2.37B+ remediation; mission shifts could cascade.", "trigger"=>"Budget amendments or Task Order 8+ awards"}
Get daily alerts with 3 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 6 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC